← All trials
NCT05531344
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 20, 2020
- Primary completion
- Jul 8, 2022
- Completion date
- Jul 8, 2022
- First posted
- Sep 7, 2022
- Last posted
- Sep 7, 2022
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- REMD Medical TechnologyLead sponsor
- Tongji UniversityCollaborator
- Central South UniversityCollaborator
- Ningbo No. 2 HospitalCollaborator
- Shandong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Ningxia Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.